TRWR‑IBD
Inflammatory Bowel Disease
PreclinicalActive
Key Facts
Indication
Inflammatory Bowel Disease
Phase
Preclinical
Status
Active
About Taiwan Resonant Waves Research
TRWR creates wearable bioelectronic devices that use electrical stimulation to treat chronic diseases such as diabetes and sleep disorders.
View full company profileTherapeutic Areas
Other Inflammatory Bowel Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Turq-101 | Turquoise Biotechnologies | Preclinical |
| GS-4875 | Gilead | Phase 2 |
| Function-based Consortium for IBD | PharmaBiome | Pre-clinical |
| Galapagos Collaboration | Scipher Medicine | Discovery/Pre-clinical |
| IBD Subclassification | Bio-Me | Research |
| Anti-iRhom2 antibodies | SciRhom | Pre-clinical |
| IBD Multi-omics Dataset | Ovation.io | Commercial |
| Noa‑001 | Noa Therapeutics | Preclinical |
| Inflectra | EMS | Phase 3 |
| IW-601 | ImmuneWalk Therapeutics | Preclinical |
| Zymfentra™ | Celltrion | Marketed |
| IBD98-M | Holy Stone Healthcare | Preclinical |